{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:30:25Z","timestamp":1769524225974,"version":"3.49.0"},"reference-count":94,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Retinal diseases are the leading cause of irreversible blindness. They affect people of all ages, from newborns in retinopathy of prematurity, through age-independent diabetic retinopathy and complications of retinal detachment, to age-related macular degeneration (AMD), which occurs mainly in the elderly. Generally speaking, the causes of all problems are disturbances in blood supply, hypoxia, the formation of abnormal blood vessels, and fibrosis. Although the detailed mechanisms underlying them are varied, the common point is the involvement of Eph receptors and ephrins in their pathogenesis. In our study, we briefly discussed the pathophysiology of the most common retinal diseases (diabetic retinopathy, retinopathy of prematurity, proliferative vitreoretinopathy, and choroidal neovascularization) and collected available research results on the role of Eph and ephrins. We also discussed the safety aspect of the use of drugs acting on Eph and ephrin for ophthalmic indications.<\/jats:p>","DOI":"10.3390\/ijms22126207","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T21:16:58Z","timestamp":1623187018000},"page":"6207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Eph Receptors and Ephrins in Retinal Diseases"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9920-4406","authenticated-orcid":false,"given":"Radoslaw","family":"Kaczmarek","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-7169","authenticated-orcid":false,"given":"Pawel","family":"Gajdzis","sequence":"additional","affiliation":[{"name":"Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Gajdzis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-Ephrin Bidirectional Signaling in Physiology and Disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00018-011-0900-6","article-title":"Eph-dependent cell-cell adhesion and segregation in development and cancer","volume":"69","author":"Nievergall","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0959-437X(02)00316-7","article-title":"Eph family functions from an evolutionary perspective","volume":"12","author":"Drescher","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/msb4100195","article-title":"Evolvable signaling networks of receptor tyrosine kinases: Relevance of robustness to malignancy and to cancer therapy","volume":"3","author":"Amit","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2004.09.002","article-title":"The role of ephrins and Eph receptors in cancer","volume":"15","author":"Surawska","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbapap.2013.04.020","article-title":"Eph\/ephrin recognition and the role of Eph\/ephrin clusters in signaling initiation","volume":"1834","author":"Nikolov","year":"2013","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-09-1710","article-title":"The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells","volume":"70","author":"Truitt","year":"2010","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1083\/jcb.201104037","article-title":"Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors","volume":"195","author":"Janes","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2006-05-023341","article-title":"EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling","volume":"108","author":"Salvucci","year":"2006","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1002\/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M","article-title":"Ephrin stimulation modulates T cell chemotaxis","volume":"32","author":"Sharfe","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0092-8674(00)00197-5","article-title":"EphB receptors interact with NMDA receptors and regulate excitatory synapse formation","volume":"103","author":"Dalva","year":"2000","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neures.2003.11.009","article-title":"EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis","volume":"48","author":"Yin","year":"2004","journal-title":"Neurosci. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nn1655","article-title":"Silencing of EphA3 through a cis interaction with ephrinA5","volume":"9","author":"Carvalho","year":"2006","journal-title":"Nat. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrm1662","article-title":"Eph receptor signalling casts a wide net on cell behaviour","volume":"6","author":"Pasquale","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2013.11.017","article-title":"Therapeutic perspectives of Eph\u2013ephrin system modulation","volume":"19","author":"Tognolini","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Huang, H. (2020). Pericyte-Endothelial Interactions in the Retinal Microvasculature. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197413"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10456-013-9398-x","article-title":"In vitro and ex vivo retina angiogenesis assays","volume":"17","author":"Rezzola","year":"2014","journal-title":"Angiogenesis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: Alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood.V100.4.1326.h81602001326_1326_1333","article-title":"Regulation of vasculogenesis and angiogenesis by EphB\/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells","volume":"100","author":"Oike","year":"2002","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:AGEN.0000037340.33788.87","article-title":"Eph receptor tyrosine kinases in angiogenesis: From development to disease","volume":"7","author":"Chen","year":"2004","journal-title":"Angiogenesis"},{"key":"ref_22","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: A comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_23","first-page":"563","article-title":"EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma","volume":"23","author":"Chen","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/0008-5472.CAN-3430-2","article-title":"Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist","volume":"64","author":"Dobrzanski","year":"2004","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-1-2","article-title":"Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis","volume":"1","author":"Cheng","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15252\/embr.201745054","article-title":"EphrinB2\/EphB4 signaling regulates non\u2014sprouting angiogenesis by VEGF","volume":"19","author":"Groppa","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1007\/s11033-020-05470-y","article-title":"The critical role of the interplays of EphrinB2\/EphB4 and VEGF in the induction of angiogenesis","volume":"47","author":"Du","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1172\/JCI0215621","article-title":"Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells","volume":"110","author":"Uemura","year":"2002","journal-title":"J. Clin. Invest."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tcm.2007.03.003","article-title":"Regulation of Angiogenesis by Eph-Ephrin Interactions","volume":"17","author":"Kuijper","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/JAHA.116.004891","article-title":"Dual Function for Mature Vascular Smooth Muscle Cells During Arteriovenous Fistula Remodeling","volume":"6","author":"Zhao","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106761","DOI":"10.1016\/j.vph.2020.106761","article-title":"Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents","volume":"131","author":"Coucha","year":"2020","journal-title":"Vascul. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1242\/jcs.00308","article-title":"EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac\/PAK pathway","volume":"116","author":"Deroanne","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/1673-5374.266044","article-title":"Molecular complexity of visual mapping: A challenge for regenerating therapy","volume":"15","author":"Medori","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.20.022403.093702","article-title":"Retinotectal mapping: New insights from molecular genetics","volume":"21","author":"Lemke","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cne.21968","article-title":"Eph\/Ephrin gradients in the retinotectal system of Rana pipiens: Developmental and adult expression patterns","volume":"514","author":"Scalia","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mcn.2014.05.005","article-title":"Multiple EphB receptors mediate dorsal-ventral retinotopic mapping via similar bi-functional responses to ephrin-B1","volume":"63","author":"McLaughlin","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/7.15.31","article-title":"Gene expression in central vs peripheral primate retina\u2014defining the foveal avascular zone","volume":"7","author":"Provis","year":"2007","journal-title":"J. Vis."},{"key":"ref_38","first-page":"45","article-title":"Differential expression of anti-angiogenic factors and guidance genes in the developing macula","volume":"15","author":"Kozulin","year":"2009","journal-title":"Mol. Vis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0898-6568(03)00072-X","article-title":"Role of ephrin B2 in human retinal endothelial cell proliferation and migration","volume":"15","author":"Steinle","year":"2003","journal-title":"Cell. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/147323000603400505","article-title":"Expression of ephrin in retinal neovascularization and iris rubeosis","volume":"34","author":"Yuuki","year":"2006","journal-title":"J. Int. Med. Res."},{"key":"ref_41","first-page":"2649","article-title":"Gradients of Eph-A6 expression in primate retina suggest roles in both vascular and axon guidance","volume":"15","author":"Kozulin","year":"2009","journal-title":"Mol. Vis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/dev.129478","article-title":"Proper closure of the optic fissure requires ephrin A5-Ephb2-JNK signaling","volume":"143","author":"Noh","year":"2016","journal-title":"Development"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bjo.2006.112185","article-title":"Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy","volume":"91","author":"Schmidt","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40478-018-0618-x","article-title":"EphrinB\/EphB forward signaling in M\u00fcller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model","volume":"6","author":"Liu","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339909787314149","article-title":"Diabetic Retinopathy and Angiogenesis","volume":"5","author":"Crawford","year":"2009","journal-title":"Curr. Diabetes Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2007.00795.x","article-title":"Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy","volume":"10","author":"Ejaz","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.113.1.147","article-title":"Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin","volume":"113","author":"Nehls","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_48","first-page":"535","article-title":"Anti-VEGF therapy for diabetic eye diseases","volume":"6","author":"Bahrami","year":"2017","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ebiom.2018.04.021","article-title":"The Novel Pathogenesis of Retinopathy Mediated by Multiple RTK Signals is Uncovered in Newly Developed Mouse Model","volume":"31","author":"Kitahara","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mao, D. (2020). Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients. BMC Ophthalmol, 5.","DOI":"10.21203\/rs.3.rs-27006\/v1"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2353\/ajpath.2006.050435","article-title":"EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown","volume":"168","author":"Ojima","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.vph.2018.05.004","article-title":"Asymmetric dimethylarginine to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway","volume":"108","author":"Du","year":"2017","journal-title":"Vascul. Pharmacol."},{"key":"ref_53","first-page":"4084","article-title":"Induced Expression of VEGFC, ANGPT, and EFNB2 and Their Receptors Characterizes Neovascularization in Proliferative Diabetic Retinopathy","volume":"60","author":"Li","year":"2019","journal-title":"Retina"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajo.2004.04.006","article-title":"Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases","volume":"138","author":"Umeda","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12098-017-2404-3","article-title":"An Update on Retinopathy of Prematurity (ROP)","volume":"84","author":"Dogra","year":"2017","journal-title":"Indian J. Pediatrics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"104846","DOI":"10.1016\/j.earlhumdev.2019.104846","article-title":"Screening and novel therapies for retinopathy of prematurity\u2013A review","volume":"138","year":"2019","journal-title":"Early Hum. Dev."},{"key":"ref_57","first-page":"1","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"2018","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1096\/fj.04-3647fje","article-title":"Huynh\u2014Do U. Hypoxia up\u2014regulates expression of Eph receptors and ephrins in mouse skin","volume":"19","author":"Vihanto","year":"2005","journal-title":"FASEB J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1167\/iovs.11-8788","article-title":"Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway","volume":"53","author":"Du","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"eColection2020","DOI":"10.1155\/2020\/7161027","article-title":"Ephrin-A5 Is Involved in Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy","volume":"2020","author":"Du","year":"2020","journal-title":"Biomed Res. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.exer.2005.09.004","article-title":"Inhibition of retinal neovascularization by soluble EphA2 receptor","volume":"82","author":"Chen","year":"2006","journal-title":"Exp. Eye Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1167\/iovs.04-0983","article-title":"Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy","volume":"46","author":"Zamora","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1167\/iovs.05-0502","article-title":"Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization","volume":"46","author":"He","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1755-3768.2009.01609.x","article-title":"Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy","volume":"89","author":"Ehlken","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1242\/jcs.00426","article-title":"Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells","volume":"116","author":"Korff","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.ATV.0000055440.89758.C2","article-title":"Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells","volume":"23","author":"Hamada","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2012.12.004","article-title":"Pathophysiology of Proliferative Vitreoretinopathy in Retinal Detachment","volume":"58","author":"Garweg","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","article-title":"Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences","volume":"51","author":"Pastor","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1167\/iovs.09-3475","article-title":"Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro","volume":"51","author":"He","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-019-0825-x","article-title":"Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis","volume":"21","author":"Wu","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ophtha.2017.04.028","article-title":"Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management","volume":"124","author":"Cheung","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0039-6257(99)00077-6","article-title":"Iatrogenic choroidal neovascularization","volume":"44","author":"Lim","year":"1999","journal-title":"Surv. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000431194","article-title":"Choroidal neovascularization secondary to myopia, infection and inflammation","volume":"55","author":"Weber","year":"2015","journal-title":"Dev. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1350-9462(01)00012-X","article-title":"Development of the primate retinal vasculature","volume":"20","author":"Provis","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00417-003-0838-y","article-title":"Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium","volume":"242","author":"Martin","year":"2004","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/atm-20-3810","article-title":"Inhibition of laser induced rats choroidal neovascularization by intravitreous injection of sEphB4-HSA","volume":"9","author":"He","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3892\/etm.2013.962","article-title":"Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody","volume":"5","author":"Su","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Baudet, S., B\u00e9cret, J., and Nicol, X. (2020). Approaches to manipulate ephrin-a:Epha forward signaling pathway. Pharmaceuticals, 13.","DOI":"10.3390\/ph13070140"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","article-title":"Eph receptor signalling: From catalytic to non-catalytic functions","volume":"38","author":"Liang","year":"2019","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-91439-8_2","article-title":"Dasatinib","volume":"212","author":"Lindauer","year":"2018","journal-title":"Small Mol. Hematol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrd4175","article-title":"Therapeutic targeting of EPH receptors and their ligands","volume":"13","author":"Boyd","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10456-010-9183-z","article-title":"The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis","volume":"13","author":"Holzer","year":"2010","journal-title":"Angiogenesis"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcdb.2011.10.023","article-title":"Targeting Eph receptors with peptides and small molecules: Progress and challenges","volume":"23","author":"Noberini","year":"2012","journal-title":"Semin Cell Dev. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-95046-4_48","article-title":"Drug-induced retinal toxicity","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.mvr.2009.01.013","article-title":"Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells","volume":"77","author":"Davies","year":"2009","journal-title":"Microvasc. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1113\/jphysiol.1956.sp005537","article-title":"A comparative study of the total carbon dioxide in the ocular fluids, cerebrospinal fluid, and plasma of some mammalian species","volume":"132","author":"Davson","year":"1956","journal-title":"J. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006324-199906000-00021","article-title":"Mouse models for the analysis of myopia: An analysis of variation in eye size of adult mice","volume":"76","author":"Zhou","year":"1999","journal-title":"Optom. Vis. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1136\/bjo.2010.182881","article-title":"Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4\/EphrinB2 signalling","volume":"94","author":"Brar","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of Intravitreal Bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/019262339902700507","article-title":"Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration","volume":"27","author":"Mordenti","year":"1999","journal-title":"Toxicol. Pathol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41598-018-19788-y","article-title":"Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1\/EphA2 system in bladder cancer","volume":"8","author":"Chu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Janes, P.W., Vail, M.E., Gan, H.K., and Scott, A.M. (2020). Antibody targeting of eph receptors in cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13050088"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:16Z","timestamp":1760163136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":94,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22126207"],"URL":"https:\/\/doi.org\/10.3390\/ijms22126207","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}